| 1 |
Meng D, Guo L, Shi D, Sun X, Shang M, Xiao S, Zhou X, Zhao Y, Wang X, Li J. Dual-sensitive and highly biocompatible O-carboxymethyl chitosan nanodroplets for prostate tumor ultrasonic imaging and treatment. Cancer Nano 2023;14:19. [DOI: 10.1186/s12645-023-00172-z] [Reference Citation Analysis]
|
| 2 |
Negron K, Kwak G, Wang H, Li H, Huang YT, Chen SW, Tyler B, Eberhart CG, Hanes J, Suk JS. A Highly Translatable Dual-arm Local Delivery Strategy To Achieve Widespread Therapeutic Coverage in Healthy and Tumor-bearing Brain Tissues. Small 2023;19:e2207278. [PMID: 36651002 DOI: 10.1002/smll.202207278] [Reference Citation Analysis]
|
| 3 |
Kumar P, Dwivedi A, Plaimas K, Sagar K, Chauhan L. Nanoengineering and nanotechnology for diagnosis and treatment of CNS and neurological diseases. Emerging Nanotechnologies for Medical Applications 2023. [DOI: 10.1016/b978-0-323-91182-5.00006-1] [Reference Citation Analysis]
|
| 4 |
Rechberger JS, Power BT, Power EA, Nesvick CL, Daniels DJ. H3K27-altered diffuse midline glioma: a paradigm shifting opportunity in direct delivery of targeted therapeutics. Expert Opin Ther Targets 2023;27:9-17. [PMID: 36744399 DOI: 10.1080/14728222.2023.2177531] [Reference Citation Analysis]
|
| 5 |
Josowitz AD, Bindra RS, Saltzman WM. Polymer nanocarriers for targeted local delivery of agents in treating brain tumors. Nanotechnology 2022;34. [PMID: 36179653 DOI: 10.1088/1361-6528/ac9683] [Reference Citation Analysis]
|
| 6 |
Gueble SE, Vasquez JC, Bindra RS. The Role of PARP Inhibitors in Patients with Primary Malignant Central Nervous System Tumors. Curr Treat Options Oncol 2022;23:1566-89. [PMID: 36242713 DOI: 10.1007/s11864-022-01024-5] [Reference Citation Analysis]
|
| 7 |
Tang H, Xie Y, Zhu M, Jia J, Liu R, Shen Y, Zheng Y, Guo X, Miao D, Pei J. Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs. Int J Nanomedicine 2022;17:3013-41. [PMID: 35836838 DOI: 10.2147/IJN.S362263] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Yang X, Yang W, Xia X, Lei T, Yang Z, Jia W, Zhou Y, Cheng G, Gao H. Intranasal Delivery of BACE1 siRNA and Rapamycin by Dual Targets Modified Nanoparticles for Alzheimer's Disease Therapy. Small 2022;:e2203182. [PMID: 35771092 DOI: 10.1002/smll.202203182] [Reference Citation Analysis]
|
| 9 |
Waris A, Ali A, Khan AU, Asim M, Zamel D, Fatima K, Raziq A, Khan MA, Akbar N, Baset A, Abourehab MAS. Applications of Various Types of Nanomaterials for the Treatment of Neurological Disorders. Nanomaterials 2022;12:2140. [DOI: 10.3390/nano12132140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Chen H, Zhou M, Zeng Y, Miao T, Luo H, Tong Y, Zhao M, Mu R, Gu J, Yang S, Han L. Biomimetic Lipopolysaccharide-Free Bacterial Outer Membrane-Functionalized Nanoparticles for Brain-Targeted Drug Delivery. Adv Sci (Weinh) 2022;9:e2105854. [PMID: 35355446 DOI: 10.1002/advs.202105854] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 11 |
Everix L, Nair S, Driver CHS, Goethals I, Sathekge MM, Ebenhan T, Vandevoorde C, Bolcaen J. Perspective on the Use of DNA Repair Inhibitors as a Tool for Imaging and Radionuclide Therapy of Glioblastoma. Cancers (Basel) 2022;14:1821. [PMID: 35406593 DOI: 10.3390/cancers14071821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Glassman PM, Nong J, Myerson JW, Zuluaga-ramirez V, Rodriguez-garcia A, Mukalel A, Omo-lamai S, Walsh LR, Kiseleva RY, Villa CH, Greineder CF, Kasner SE, Weissman D, Mitchell MJ, Muro S, Persidsky Y, Brenner JS, Muzykantov VR, Marcos-contreras OA. Targeted nanocarriers coopting pulmonary leukocytes for drug delivery to the injured brain.. [DOI: 10.1101/2022.02.04.479150] [Reference Citation Analysis]
|
| 13 |
Melancon MP, Yevich S, Avritscher R, Swigost A, Lu L, Tian L, Damasco JA, Dixon K, Cortes AC, Munoz NM, Liang D, Liu D, Tam AL. A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liver. Drug Deliv 2021;28:240-51. [PMID: 33501859 DOI: 10.1080/10717544.2020.1869863] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Heravi Shargh V, Luckett J, Bouzinab K, Paisey S, Turyanska L, Singleton WGB, Lowis S, Gershkovich P, Bradshaw TD, Stevens MFG, Bienemann A, Coyle B. Chemosensitization of Temozolomide-Resistant Pediatric Diffuse Midline Glioma Using Potent Nanoencapsulated Forms of a N(3)-Propargyl Analogue. ACS Appl Mater Interfaces 2021;13:35266-80. [PMID: 34310112 DOI: 10.1021/acsami.1c04164] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 15 |
D'auria I, Santulli F, Ciccone F, Giannattasio A, Mazzeo M, Pappalardo D. Synthesis of Semi‐Aromatic Di‐Block Polyesters by Terpolymerization of Macrolactones, Epoxides, and Anhydrides. ChemCatChem 2021;13:3303-3311. [DOI: 10.1002/cctc.202100434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 16 |
Khan NU, Ni J, Ju X, Miao T, Chen H, Han L. Escape from abluminal LRP1-mediated clearance for boosted nanoparticle brain delivery and brain metastasis treatment. Acta Pharm Sin B 2021;11:1341-54. [PMID: 34094838 DOI: 10.1016/j.apsb.2020.10.015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 17 |
Ngowi EE, Wang YZ, Qian L, Helmy YASH, Anyomi B, Li T, Zheng M, Jiang ES, Duan SF, Wei JS, Wu DD, Ji XY. The Application of Nanotechnology for the Diagnosis and Treatment of Brain Diseases and Disorders. Front Bioeng Biotechnol 2021;9:629832. [PMID: 33738278 DOI: 10.3389/fbioe.2021.629832] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 18 |
Wolpaw AJ, Bayliss R, Büchel G, Dang CV, Eilers M, Gustafson WC, Hansen GH, Jura N, Knapp S, Lemmon MA, Levens D, Maris JM, Marmorstein R, Metallo SJ, Park JR, Penn LZ, Rape M, Roussel MF, Shokat KM, Tansey WP, Verba KA, Vos SM, Weiss WA, Wolf E, Mossé YP. Drugging the "Undruggable" MYCN Oncogenic Transcription Factor: Overcoming Previous Obstacles to Impact Childhood Cancers. Cancer Res 2021;81:1627-32. [PMID: 33509943 DOI: 10.1158/0008-5472.CAN-20-3108] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 19 |
Hsu JF, Chu SM, Liao CC, Wang CJ, Wang YS, Lai MY, Wang HC, Huang HR, Tsai MH. Nanotechnology and Nanocarrier-Based Drug Delivery as the Potential Therapeutic Strategy for Glioblastoma Multiforme: An Update. Cancers (Basel) 2021;13:E195. [PMID: 33430494 DOI: 10.3390/cancers13020195] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 18.0] [Reference Citation Analysis]
|
| 20 |
Khot S, Rawal SU, Patel MM. Dissolvable-soluble or biodegradable polymers. Drug Delivery Devices and Therapeutic Systems 2021. [DOI: 10.1016/b978-0-12-819838-4.00024-9] [Reference Citation Analysis]
|
| 21 |
Barnieh FM, Loadman PM, Falconer RA. Progress towards a clinically-successful ATR inhibitor for cancer therapy. Current Research in Pharmacology and Drug Discovery 2021;2:100017. [DOI: 10.1016/j.crphar.2021.100017] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
|
| 22 |
Cano A, Espina M, García ML. Recent Advances on Antitumor Agents-loaded Polymeric and Lipid-based Nanocarriers for the Treatment of Brain Cancer. Curr Pharm Des 2020;26:1316-30. [PMID: 31951159 DOI: 10.2174/1381612826666200116142922] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 23 |
Fu S, Zhang P. Surface Coating Modified Polyglycolide (PGA) Braided Threads as Potential Thread-embedding Materials. Fibers Polym 2020;21:2401-6. [DOI: 10.1007/s12221-020-1364-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 24 |
Hu X, Yang F, Liao Y, Li L, Zhao G, Zhang L. Docetaxel-Loaded Cholesterol-PEG Co-Modified Poly (n-Butyl) Cyanoacrylate Nanoparticles for Antitumor Drug Pulmonary Delivery: Preparation, Characterization, and in vivo Evaluation. Int J Nanomedicine 2020;15:5361-76. [PMID: 32801694 DOI: 10.2147/IJN.S249511] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 25 |
Zhu J, Jiang G, Hong W, Zhang Y, Xu B, Song G, Liu T, Hong C, Ruan L. Rapid gelation of oxidized hyaluronic acid and succinyl chitosan for integration with insulin-loaded micelles and epidermal growth factor on diabetic wound healing. Mater Sci Eng C Mater Biol Appl 2020;117:111273. [PMID: 32919637 DOI: 10.1016/j.msec.2020.111273] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 26 |
Xu Y, Wei L, Wang H. Progress and perspectives on nanoplatforms for drug delivery to the brain. Journal of Drug Delivery Science and Technology 2020;57:101636. [DOI: 10.1016/j.jddst.2020.101636] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Sun Y, Li L, Xie H, Wang Y, Gao S, Zhang L, Bo F, Yang S, Feng A. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery. Int J Nanomedicine 2020;15:3137-60. [PMID: 32440115 DOI: 10.2147/IJN.S247935] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 28 |
Karimy JK, Reeves BC, Kahle KT. Targeting TLR4-dependent inflammation in post-hemorrhagic brain injury. Expert Opin Ther Targets 2020;24:525-33. [PMID: 32249624 DOI: 10.1080/14728222.2020.1752182] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 29 |
Gorecki L, Andrs M, Rezacova M, Korabecny J. Discovery of ATR kinase inhibitor berzosertib (VX-970, M6620): Clinical candidate for cancer therapy. Pharmacol Ther 2020;210:107518. [PMID: 32109490 DOI: 10.1016/j.pharmthera.2020.107518] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 30 |
Denkova AG, Liu H, Men Y, Eelkema R. Enhanced Cancer Therapy by Combining Radiation and Chemical Effects Mediated by Nanocarriers. Adv Therap 2020;3:1900177. [DOI: 10.1002/adtp.201900177] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 31 |
Yokel RA. Nanoparticle brain delivery: a guide to verification methods. Nanomedicine 2020;15:409-32. [DOI: 10.2217/nnm-2019-0169] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 32 |
Meng D, Guo L, Shi D, Sun X, Shang M, Zhou X, Li J. Charge-conversion and ultrasound-responsive O-carboxymethyl chitosan nanodroplets for controlled drug delivery. Nanomedicine (Lond) 2019;14:2549-65. [PMID: 31271101 DOI: 10.2217/nnm-2019-0217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 33 |
Tinajero-díaz E, Martínez de Ilarduya A, Muñoz-guerra S. Synthesis and properties of diblock copolymers of ω-pentadecalactone and α-amino acids. European Polymer Journal 2019;116:169-79. [DOI: 10.1016/j.eurpolymj.2019.04.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 34 |
Nosrati H, Abhari F, Charmi J, Davaran S, Danafar H. Multifunctional nanoparticles from albumin for stimuli-responsive efficient dual drug delivery. Bioorg Chem 2019;88:102959. [PMID: 31075743 DOI: 10.1016/j.bioorg.2019.102959] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 35 |
Chen J, Li L, Gao J. Biomaterials for local drug delivery in central nervous system. International Journal of Pharmaceutics 2019;560:92-100. [DOI: 10.1016/j.ijpharm.2019.01.071] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 36 |
Daniel Mihai Teleanu, Cristina Chircov, Alexandru Mihai Grumezescu, Raluca Ioana Teleanu. Neuronanomedicine: An Up-to-Date Overview. Pharmaceutics 2019;11:101. [PMID: 30813646 DOI: 10.3390/pharmaceutics11030101] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 37 |
Seo YE, Suh HW, Bahal R, Josowitz A, Zhang J, Song E, Cui J, Noorbakhsh S, Jackson C, Bu T, Piotrowski-Daspit A, Bindra R, Saltzman WM. Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma. Biomaterials 2019;201:87-98. [PMID: 30802686 DOI: 10.1016/j.biomaterials.2019.02.016] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 12.3] [Reference Citation Analysis]
|
| 38 |
Jin P, Sha R, Zhang Y, Liu L, Bian Y, Qian J, Qian J, Lin J, Ishimwe N, Hu Y, Zhang W, Liu Y, Yin S, Ren L, Wen LP. Blood Circulation-Prolonging Peptides for Engineered Nanoparticles Identified via Phage Display. Nano Lett 2019;19:1467-78. [PMID: 30730145 DOI: 10.1021/acs.nanolett.8b04007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 39 |
Teleanu DM, Chircov C, Grumezescu AM, Volceanov A, Teleanu RI. Impact of Nanoparticles on Brain Health: An Up to Date Overview. J Clin Med 2018;7:E490. [PMID: 30486404 DOI: 10.3390/jcm7120490] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 18.4] [Reference Citation Analysis]
|
| 40 |
Shen S, Li Y, Xiao Y, Zhao Z, Zhang C, Wang J, Li H, Liu F, He N, Yuan Y, Lu Y, Guo S, Wang Y, Liao W, Liao Y, Chen Y, Bin J. Folate-conjugated nanobubbles selectively target and kill cancer cells via ultrasound-triggered intracellular explosion. Biomaterials 2018;181:293-306. [PMID: 30096563 DOI: 10.1016/j.biomaterials.2018.07.030] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
|
